The FDA has approved Merck's drug to treat a rare, deadly lung disease: Merck bought the company developing the drug for $11.5 billion in 2021
qz.com/fda-merck-winrevair-approval-lung-pulmonary-disease-1851368126
Paid articlePaid
J&J gets new opportunity to contest evidence linking talc to cancer: Johnson & Johnson will get a new chance to contest the scientific evidence linking talc ...
reut.rs/3TBk7p1
Exclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told...
reut.rs/3xlt526
Blackstone cures two ailments in one Moderna shot: Lending to a company is fine; taking a piece of its most promising investments is better ...
reuters.com/breakingviews/blackstone-cures-two-ailments-one-moderna-shot-2024-03-27/
Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices: Sen. Bernie Sanders (I-Vt.) called on pharmaceutical manufacturer Novo Nordisk to slash prices ...
thehill.com/policy/healthcare/4560323-sanders-calls-for-novo-nordisk-slash-ozempic-wegovy-prices/
Reddit (RDDT) IPO: Investors Want More But Revival Will Take a While: Initial public offerings are back. Maybe.
bloomberg.com/news/articles/2024-03-24/reddit-galderma-fire-ipo-starting-gun-now-investors-want-more
RFK Jr names wealthy lawyer, 'warrior mom' Shanahan as running mate: Independent U.S. presidential candidate Robert F. Kennedy Jr. on Tuesday picked wealthy ...
reuters.com/world/us/robert-f-kennedy-jr-name-vice-presidential-pick-tuesday-2024-us-election-bid-2024-03-26/
Quick Glance: RFK Jr. selects attorney Nicole Shanahan as his VP candidate
- Independent presidential hopeful, Robert F. Kennedy Jr., revealed on Tuesday that Nicole Shanahan, a wealthy attorney and entrepreneur in the San Francisco Bay Area, is joining his campaign as his vice presidential candidate.
- Shanahan has been actively contributing to Kennedy's campaign and his super PAC, solidifying her position as a potential vice presidential candidate.
- Additionally, Shanahan has established a foundation advocating for issues such as reproductive longevity and equality, criminal justice reform, and a sustainable planet.
- Kennedy has a strong emphasis on anti-vaccine efforts and has incorporated anti-vaccine activists into his campaign team to bolster his stance on the matter.
J&J in talks to buy Shockwave Medical, WSJ reports: Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal ...
reuters.com/markets/deals/johnson-johnson-considers-deal-buy-shockwave-medical-wsj-reports-2024-03-26/
Century Health, now with $2M, taps AI to give pharma access to good patient data: Century Health is applying AI to clinical data to uncover new applications for ...
techcrunch.com/2024/03/27/century-health-2m-ai-pharma-patient-data/
Novo Nordisk’s drug semaglutide has made the company the most valuable in Europe. But portfolio manager Randy Watts told @Reuters this is just the beginning for ... Show more
BioNTech gets US agency notice over default on COVID vaccine royalties: BioNTech said on Monday the U.S. National Institutes of Health has sent a notice to the ...
reuters.com/business/healthcare-pharmaceuticals/biontech-gets-us-agency-notice-over-default-covid-vaccine-royalties-2024-03-25/
Novo ready to seek German insurance coverage of Wegovy for heart use: Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for ...
reuters.com/business/healthcare-pharmaceuticals/novo-ready-seek-german-insurance-coverage-wegovy-heart-use-2024-03-25/
Which OTC Health Products Are Best? New Report Claims to Know: The number and variety of over-the-counter health products on the market — from cough syrups to ...
webmd.com/drug-medication/news/20240328/report-names-best-otc-health-products
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
reuters.com/business/healthcare-pharmaceuticals/weight-loss-drug-deals-drive-around-4-gerresheimer-yearly-growth-ceo-says-2024-03-29/
Zoetis in EU antitrust crosshairs over rival dog pain medicine: EU antitrust regulators have started an investigation into whether Zoetis blocked the market ...
reuters.com/business/healthcare-pharmaceuticals/eu-targets-zoetis-antitrust-investigation-over-dog-medicines-2024-03-26/
Popular Appetite Suppressant Ozempic Can Be Made For Less Than $5 a Month, New Research Suggests
entrepreneur.com/business-news/ozempic-could-be-profitably-manufactured-much-cheaper-study/471823
Even a new and improved COVID vaccine isn't budging Moderna stock: The pharma company said its updated vaccine is showing a stronger immune response than the ...
qz.com/moderna-stock-covid19-vaccine-trial-results-1851367032
Paid articlePaid
Nvidia's AI ambitions in medicine and health care are becoming clear: Applying Nvidia AI chips to health care, whether it's biotechnology, chemicals ...
cnbc.com/2024/03/24/nvidias-ai-ambitions-in-medicine-and-health-care-are-becoming-clear.html
CVS, Kaiser, and Elevance are among the first Medicare plans to start covering Wegovy
qz.com/cvs-kaiser-elevance-medicare-1851373235
Paid articlePaid
AstraZeneca will cap inhaler costs at $35 per month: The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device ...
washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/
Quick Glance: AstraZeneca caps out-of-pocket costs for inhalers
- AstraZeneca announced it will cap out-of-pocket costs for inhaled respiratory products in the US at $35 per month, following a similar move by rival Boehringer Ingelheim.
- This decision comes amidst increasing political scrutiny of high drug prices in the US, particularly for inhalers used to treat asthma and chronic obstructive pulmonary disease.
- The out-of-pocket cost cap will be effective from June 1 for AstraZeneca's entire respiratory product portfolio, including popular inhalers like Airsupra, Bevespi Aerosphere, and Breztri Aerosphere.
- AstraZeneca CEO Pascal Soriot emphasized the need for comprehensive healthcare reform to ensure patients can afford essential medications.
After earnings plunge, BioNTech pins hopes on cancer drug launches: Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during ...
reuters.com/business/healthcare-pharmaceuticals/after-earnings-plunge-biontech-pins-hopes-cancer-drug-launches-2024-03-20/
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Pharmacies take appeal of $650 mln opioid award to Ohio top court: Pharmacy operators CVS , Walmart and Walgreens on Tuesday urged Ohio's highest court to ...
reuters.com/legal/litigation/pharmacies-take-appeal-650-mln-opioid-award-ohio-top-court-2024-03-26/
Denmark's new Nvidia AI supercomputer will come online this year: Two of the biggest winners over the past year — chipmaker Nvidia and pharmaceutical drug maker ...
thenextweb.com/news/denmarks-new-nvidia-ai-supercomputer-will-come-online-this-year
Ozempic maker Novo Nordisk has an 'unsustainable' level of stressed out workers, CEO says
qz.com/novo-nordisk-ceo-lars-fruergaard-jorgensen-reducing-str-1851359937
Paid articlePaid
HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches
medscape.org/viewarticle/1000191
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag: Orchard Therapeutics, a unit of Japan's Kyowa Kirin , priced its newly approved ...
reuters.com/business/healthcare-pharmaceuticals/kyowa-kirins-gene-therapy-most-expensive-us-drug-with-43-mln-price-tag-2024-03-20/
Europe’s IPO window opens slowly for buyout barons: podcast: CVC floated beauty retailer Douglas, whose shares fell, while EQT received a warmer welcome for ...
reuters.com/breakingviews/europes-ipo-window-opens-slowly-buyout-barons-podcast-2024-03-28/
EU regulator delays decision on Eisai-Biogen Alzheimer's drug: The European Union's medicines regulator has delayed its decision on Eisai and partner Biogen's ...
reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-does-not-refer-eisai-biogen-alzheimers-drug-meeting-notes-2024-03-22/
Bonuses Padded by Cryptic ESG Claims Draw Activist Scrutiny: As companies increasingly tie executive pay to ESG, there’s evidence to suggest the add-on is being ...
bloomberg.com/news/articles/2024-03-20/bonuses-padded-by-cryptic-esg-claims-draw-activist-scrutiny
Germany's health insurance could cover Wegovy for strokes, heart conditions, agency says
reuters.com/business/healthcare-pharmaceuticals/germanys-health-insurance-could-cover-wegovy-strokes-heart-conditions-agency-2024-03-22/
Viking Therapeutics stock jumps more than 25% on promising weight loss pill data: The Viking study results add to the growing excitement around the biotech ...
cnbc.com/2024/03/26/viking-therapeutics-weight-loss-pill-shows-positive-study-results.html
Boots to sell Covid-19 jabs in high street first - but they're not cheap: The single-dose Pfizer vaccine will be offered at 50 stores from April 1 to anyone aged ...
chroniclelive.co.uk/news/uk-news/boots-sell-covid-19-pfizer-28892311
Bayer to seek approval for menopausal relief drug after third trial win: Bayer said on Tuesday that it would request regulatory approval for its menopause drug ...
reuters.com/business/healthcare-pharmaceuticals/bayer-seek-approval-menopausal-relief-drug-after-third-trial-win-2024-03-19/
In Early Study, People on Weight Loss Pill Lost 13% of Their Body Weight: Novo Nordisk is testing a new weight-loss pill, called amycretin, that is said to lead ...
healthline.com/health-news/in-early-study-people-on-weight-loss-pill-lost-13-of-their-body-weight
The most expensive drugs in the world — starting at the low price of $1 million: The majority of these drugs treat illness affecting less than 200,000 people
qz.com/most-expensive-drugs-2024-lenmeldy-hemgenix-elevidys-1851356958
Paid articlePaid
Environmental violations troubled Sun Pharma group donated Rs 31.5 crore to political parties
reporters-collective.in/trc/sun-pharma-group-donated-rs-31-5-crore-to-political-parties
Quick Glance: Environmental Concerns: Significant Donations by Sun Pharma Group to Political Parties
- During the financial year 2019-20, Sun Pharma Laboratories Limited (SPLL), a subsidiary of Sun Pharmaceutical Industries Limited, made substantial donations to political parties through electoral bonds.
- The acquisition of electoral bonds worth Rs 21.5 crore on April 15, 2019, and Rs 10 crore on May 8, 2019 was also carried out by SPLL.
- In 2022, Sun Pharmaceutical Industries faced legal issues due to the planned expansion of a bulk drug manufacturing unit in the Kancheepuram district, Tamil Nadu.
- ICRA, the ratings agency, has expressed concerns about Sun Pharma's environmental record and highlighted the close collaboration between SPLL, the subsidiary of Sun Pharmaceutical Industries Limited responsible for political donations, and its parent company.
Novo Nordisk foundation to place more grants outside Denmark: The Novo Nordisk Foundation, top shareholder of Danish obesity drugmaker Novo Nordisk ...
reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-foundation-place-more-grants-outside-denmark-2024-03-18/
AstraZeneca to buy Fusion Pharma for $2 billion in cash: AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals ...
reuters.com/markets/deals/astrazeneca-buy-fusion-pharma-2-billion-cash-2024-03-19/
GSK to cap out-of-pocket inhaler costs in US: British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and ...
reuters.com/business/healthcare-pharmaceuticals/gsk-cap-out-of-pocket-inhaler-costs-us-2024-03-20/
US FDA grants full approval to AbbVie's ovarian cancer therapy: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for ...
reut.rs/496Piyi
Skin care company Galderma's shares soar on stock market debut: Skin care company Galderma's shares soared on Friday after the maker of cosmetic fillers and ...
reuters.com/business/retail-consumer/skin-care-company-galdermas-shares-soar-stock-market-debut-2024-03-22/
The pharmaceutical landscape has been transformed by one drug - semaglutide. It's made Novo Nordisk the most valuable company in Europe ... Show more
Pfizer offloads $3.9 bln stake in Sensodyne-maker Haleon: Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer ...
reuters.com/markets/deals/pfizer-offloads-39-bln-stake-sensodyne-maker-haleon-2024-03-19/
Lonza to buy biologics site from Roche in U.S. for $1.2 bln: Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the ...
reuters.com/markets/deals/lonza-acquire-biologics-site-roche-us-12-bln-2024-03-20/
First over-the-counter birth control pill hits store shelves: Opill, the first birth control pill approved for people to buy without a prescription ...
nbcnews.com/health/health-news/birth-control-pill-over-the-counter-available-stores-rcna144470
Wegovy to be covered by US Medicare for heart disease patients: Heart patients insured under the U.S. Medicare program would be covered for Novo Nordisk's ...
reuters.com/business/healthcare-pharmaceuticals/wegovy-be-covered-by-us-medicare-heart-disease-patients-2024-03-21/
Novo Nordisk's once-weekly basal insulin icodec recommended for marketing approval in Europe
reut.rs/4cq2Nfm
The morning after pill will soon be sold at convenience stores across the U.S.: Cadence OTC is making its emergency contraception more widely available after CVS ...
qz.com/morning-after-pill-cadence-otc-convenience-stores-1851346741
Paid articlePaid
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
Walmart wants more wealthy shoppers: The retail giant is making renovations to its sales floors and its assortment of brands
qz.com/walmart-wealthy-shoppers-1851355757
Paid articlePaid
The rise of Ozempic maker Novo Nordisk to one of the world's most valuable companies
qz.com/novo-nordisk-ozempic-wegovy-history-1851340401
Paid articlePaid
Supreme Court skeptical of limiting access to abortion pill : The Supreme Court is hearing oral arguments on whether to restrict access to the abortion pill ...
washingtonpost.com/politics/2024/03/26/abortion-pill-supreme-court-arguments-mifepristone/
First over-the-counter birth control pill now for sale online: Opill, an over-the-counter birth control pill, goes on sale online today. The pill is expected to ...
npr.org/sections/health-shots/2024/03/04/1235404522/opill-over-counter-birth-control-pill-contraceptive-shop
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
cnbc.com/2024/03/27/altimmune-weight-loss-drug-minimized-muscle-mass-loss-in-trial.html
US appeals court revives Regeneron's antitrust lawsuit against Novartis: A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals ...
reuters.com/legal/us-appeals-court-revives-regenerons-antitrust-lawsuit-against-novartis-2024-03-18/
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soon
forbes.com/sites/roberthart/2024/03/27/heres-why-ozempic-and-mounjaro-rivals-wont-topple-weight-loss-drugmakers-novo-nordisk-and-eli-lilly-anytime-soon/
Toxic Heavy Metals Found in Cannabis Vaping Liquids, Even Before Heated: Researchers found nano-sized toxic metal particles in cannabis vaping liquids ...
healthline.com/health-news/toxic-heavy-metals-cannabis-vaping-liquids
Novo Nordisk's weight loss drug Wegovy could soon be covered by Medicare: The FDA expanded the approved use of Wegovy to include reducing the risk of serious ...
qz.com/wegovy-novo-nordisk-medicare-fda-1851339143
Paid articlePaid
The weight loss drug race has Amgen coming for Novo Nordisk and Eli Lilly: Amgen is testing whether its new drug, a potential competitor to Novo Nordisk's hugely ...
qz.com/amgen-novo-nordisk-eli-lilly-wegovy-zepbound-1851361723
Paid articlePaid
Duluth pub responds to Cargill's diss by serving Cheerios with its beer: The community is also donating boxes of the cereal to local food shelves.
startribune.com/duluth-responds-to-cargills-diss-by-serving-cheerios-with-its-beer/600354181/
Paid articlePaid
US FDA panel backs expanded use of J&J, Bristol Myers' CAR-T therapies: Advisers to the U.S. health regulator voted in favor of allowing the use of Johnson & ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-unanimously-backs-expanded-use-jjs-car-t-therapy-2024-03-15/
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss: Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are headliners in the expected ...
investors.com/etfs-and-funds/etfs/weight-loss-drugs-feisty-rivals-take-on-eli-lilly-novo-nordisk/
Lung cancer vaccine being developed by UK researchers : Using technology similar to that used to create the AstraZeneca Covid-19 vaccine ...
itv.com/news/2024-03-22/lung-cancer-vaccine-being-developed-by-uk-researchers
Viatris generic hypertension drug does not violate J&J patents, US court says: Generic drugmaker Viatris has convinced a federal judge in West Virginia that its ...
reuters.com/legal/litigation/viatris-generic-hypertension-drug-does-not-violate-jj-patents-us-court-says-2024-03-15/
Covid vaccine to be sold on high street for first time: Covid jabs will be sold on the high street for £99 from next week, as Boots becomes the first major ...
thetimes.co.uk/article/covid-vaccine-jab-high-street-uk-boots-gwvjsdzbz
Paid articlePaid
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/
Biontech's business collapses massively: buy shares cheaply now?: Corona is over, and the numbers and share price at vaccine manufacturer Biontech are collapsing ...
capital.de/geld-versicherungen/biontechs-geschaeft-bricht-massiv-ein--aktie-jetzt-guenstig-kaufen--34561014.html
Paid articlePaid
Quick Glance: Biontech: Massive Business Decline Post-COVID
- As COVID ends, Biontech faces declining numbers and stock prices.
- A study reveals the significant impact of COVID on life expectancy.
- Biontech gained global recognition with the mRNA vaccine.
- The company is now focusing on new treatments for cancer to bounce back.
From IVF to birth control, Supreme Court abortion pill case could spark challenges to other drugs
nbcnews.com/politics/supreme-court/ivf-birth-control-supreme-court-abortion-pill-case-spark-challenges-dr-rcna144435
London's FTSE 100 opens higher on miners' boost: The UK's FTSE 100 inched higher on Monday as metal miners rose on upbeat economic data from China ...
reuters.com/markets/europe/londons-ftse-100-opens-higher-miners-boost-2024-03-18/
The World's Most Innovative Companies of 2024: Fast Company's 2024 ranking of the World's Most Innovative Companies features Nvidia at No ...
fastcompany.com/most-innovative-companies/list
Daily Brief: Boeing's CEO quits, Sam Altman’s Reddit IPO win, Novo Nordisk’s next bet
qz.com/emails/daily-brief/1851364856/boeing-dave-calhoun-novo-nordisk-cardior-pharmaceutica
Paid articlePaid
Pharmacy unionizing efforts build momentum as a CVS Omnicare in Las Vegas seeks to join
usatoday.com/story/news/investigations/2024/03/25/las-vegas-cvs-join-pharmacy-union-guid/73089500007/
First OTC birth control pill in the US now available in some stores: For the first time, women in the US can walk into a store and buy a supply of birth control ...
cnn.com/2024/03/28/health/opill-otc-birth-control-pill-in-stores/
Paid articlePaid
Novo Nordisk’s weight-loss wonder drugs could also help with dementia, liver disease, and more
fastcompany.com/91042014/novo-nordisk-most-innovative-companies-2024
Canadian miner Teck's Elk Valley clean up could cost at least C$6.4 bln, environment group says
reuters.com/world/americas/canadian-miner-tecks-elk-valley-clean-up-could-cost-least-c64-bln-environment-2024-03-19/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics